Maha Katabi, Director at Vera Therapeutics, holds 2.79M shares in Vera Therapeutics (Ticker: VERA), holds 0.00 shares in RayzeBio, Inc. (Ticker: RYZB), holds 3.76M shares in Aerovate Therapeutics (Ticker: AVTE). Most recently, Maha Katabi Sold ― shares of Vera Therapeutics on Mar 25, 2024 for an estimated value of 34.10M.
What is the percentage of profitable transactions made by Maha Katabi?
The percentage of profitable transactions made by Maha Katabi is 50%.
What is the average return per transaction made by Maha Katabi?
The average return per transaction made by Maha Katabi is 1.50%.
What stocks does Maha Katabi hold?
Maha Katabi holds: VERA, AVTE, RYZB stocks.
What was Maha Katabi’s latest transaction?
Maha Katabi latest transaction was an Informative Sell of $34.10M.
What was Maha Katabi's most profitable transaction?
Maha Katabi’s most profitable transaction was an Informative Buy of VERA stock on May 18, 2021. The return on the trade was 32.80%.
What is Maha Katabi's role in Vera Therapeutics?
Maha Katabi's role in Vera Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.